Immunotherapy with histamine and interleukin 2 in malignant melanoma with liver metastasis

被引:14
作者
Agarwala, SS
Hellstrand, K
Gehlsen, K
Naredi, P
机构
[1] Gothenburg Univ, Dept Virol, S-41346 Gothenburg, Sweden
[2] Univ Pittsburgh, Inst Canc, Melanoma Ctr, Pittsburgh, PA USA
[3] Maxim Pharmaceut, San Diego, CA USA
[4] Univ Umea Hosp, Dept Surg, S-90185 Umea, Sweden
关键词
D O I
10.1007/s00262-004-0537-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:840 / 841
页数:2
相关论文
共 11 条
  • [1] Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma
    Agarwala, SS
    Glaspy, J
    O'Day, SJ
    Mitchell, M
    Gutheil, J
    Whitman, E
    Gonzalez, R
    Hersh, E
    Feun, L
    Belt, R
    Meyskens, F
    Hellstrand, K
    Wood, D
    Kirkwood, JM
    Gehlsen, KR
    Naredi, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) : 125 - 133
  • [2] ATKINS MB, 2002, SEMIN ONCOL, V3, pS7
  • [3] HISTAMINE IN IMMUNOTHERAPY OF ADVANCED MELANOMA - A PILOT-STUDY
    HELLSTRAND, K
    NAREDI, P
    LINDNER, P
    LUNDHOLM, K
    RUDENSTAM, CM
    HERMODSSON, S
    ASZTELY, M
    HAFSTROM, L
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1994, 39 (06) : 416 - 419
  • [4] HELLSTRAND K, 1994, J IMMUNOL, V153, P4940
  • [5] HELLSTRAND K, 1990, J IMMUNOL, V145, P4365
  • [6] Histamine in cancer immunotherapy: A preclinical background
    Hellstrand, K
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (03) : 35 - 40
  • [7] Tumor-induced immune dysfunction
    Kiessling, R
    Wasserman, K
    Horiguchi, S
    Kono, K
    Sjöberg, J
    Pisa, P
    Petersson, M
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1999, 48 (07) : 353 - 362
  • [8] Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell- and natural killer cell-mediated cytotoxicity
    Kono, K
    SalazarOnfray, F
    Petersson, M
    Hansson, J
    Masucci, G
    Wasserman, K
    Nakazawa, T
    Anderson, P
    Kiessling, R
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (06) : 1308 - 1313
  • [9] Prognostic factors in metastatic melanoma: A pooled analysis of Eastern Cooperative Oncology Group trials
    Manola, J
    Atkins, M
    Ibrahim, J
    Kirkwood, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (22) : 3782 - 3793
  • [10] PHYSIOLOGY AND PHYSIOPATHOLOGY OF RETICULOENDOTHELIAL SYSTEM
    SABA, TM
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1970, 126 (06) : 1031 - +